Blood Test Can Predict Short-Term Survival Among Seniors
via HealthDayFRIDAY, Feb. 27, 2026 — An experimental blood test can predict whether seniors have long to live, a new study says.
The genetics-based blood test predicted two-year survival with accuracy as high as 86% among hundreds of seniors, researchers reported Feb. 24 in the journal Aging Cell.
The test is based on PIWI-interacting RNA (piRNA), a class of genetic molecules that regulate development, regeneration and immune response in the human body.
“The combination of just a few piRNAs was the strongest predictor of two-year survival in older adults — stronger than age, lifestyle habits or any other health measures we examined,” said senior researcher Dr. Virginia Byers Kraus, a professor of medicine, pathology and orthopaedic surgery at Duke University in Durham, North Carolina.
“What surprised us most was that this powerful signal came from a simple blood test,” Kraus said in a news release.
For the study, researchers measured piRNAs found in blood samples taken from nearly 1,300 seniors 71 and older.
Results showed that lower levels of certain piRNAs were strongly linked to longer survival.
Specifically, a set of six piRNAs alone predicted the odds that a senior would live beyond two years with up to 86% accuracy. Participants who lived longer consistently had lower levels of these piRNAs.
“We know very little about piRNAs in the blood, but what we’re seeing is that lower levels of certain specific ones is better,” Kraus said. “When these molecules are present in higher amounts, it may signal that something in the body is off‑track. Understanding why could open new possibilities for therapies that promote healthy aging.”
These piRNAs outperformed age, cholesterol, physical activity and more than 180 other clinical measures in predicting short-term survival, researchers found.
Lifestyle factors became more influential when predicting longer-term survival, but piRNAs continued to provide valuable insights into a person’s biology, researchers added.
“These small RNAs are like micromanagers in the body, helping control many processes that affect health and aging,” Kraus said. “We are only beginning to understand how powerful they are.”
The team next plans to study how treatments, lifestyle changes or medications might alter a person’s piRNA levels. They also plan to compare piRNA levels in blood to those found in tissues, to better understand how the molecules function.
“This research suggests we should be able to identify short-term survival risk using a practical, minimally invasive blood test — with the ultimate goal of improving health as we age,” Kraus said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-28 08:27
Read more
- Volume Rendering of Myocardium, Cardiac Valves Enables Visualization
- Calquence Plus Venetoclax Approved in the US as First All-Oral, Fixed-Duration Combination for Patients with Chronic Lymphocytic Leukemia in the 1st-Line Setting
- Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood
- FDA Approves Hernexeos, the First Targeted Therapy for Adults with HER2-Mutant Advanced NSCLC as an Initial Treatment Option
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- FDA Approves Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the Only EGFR-Targeted Therapy that can be Administered Once a Month
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions